Inside the Lab Industry: Quest, LabCorp Post Improved Volumes, Revenue for Third Quarter

Could the third quarter be the charm for the big national labs? Both Quest Diagnostics and LabCorp reported solid earnings for the quarter ending Sept. 30, indicating they were back on track toward … [Read more...]

Metamark Introduces Assay That Determines Aggressiveness of Prostate Cancer

Massachusetts-based Metamark Genetics has released a new molecular-based prostate cancer test that can better pinpoint the overall aggressiveness of the disease. The test, known as the ProMark, is … [Read more...]

Aurora Diagnostics Acquires West Georgia Pathology

Aurora Diagnostics, the Florida-based pathology operator, has entered the Georgia market with the acquisition of West Georgia Pathology LLC. The hospital-based practice is located in Carrolton, Ga., … [Read more...]

Foundation Medicine Strikes Deal for Testing in China

Foundation Medicine has struck a deal with an overseas firm to offer some of its assays in China. Under the terms of the deal reached with Shanghai-based WuXi PharmaTech Inc., the Cambridge, … [Read more...]

Arizona Lab Develops $99 Molecular Lung Cancer Test

A small laboratory in Arizona has brought to market a product the Cancer community is sorely in need of: a low-cost molecular test that can detect all forms of lung cancer at all stages of the … [Read more...]

Inside the Lab Industry: Laboratory M&A: Volume of Deals Mostly Unchanged From a Year Ago

As 2014 comes to a close, the volume of mergers and acquisitions in the laboratory sector during the calendar year is hewing close to what transacted in 2013, although there is more movement in the … [Read more...]

A 2015 Preview for the Laboratory Sector

The year 2014 was a challenging one for laboratories. They continued to confront cuts in reimbursement even as the Affordable Care Act brought millions of more Americans into the insurance fold for … [Read more...]

Venture Capital and Laboratories: A Lingering Question Mark

Despite the vastness of the health care industry, the laboratory sector is one business branch with minimal leverage. Despite its ubiquity - what patient hasn't undergone a lab test? - it still only … [Read more...]

Through Deals and an Executive Revamp, Aurora Diagnostics Strains Toward the Black

Debt-laden Aurora Diagnostics has all but revamped its executive ranks and engaged in several deals in the past few months that has refocused the Florida-based laboratory on pathology and … [Read more...]